cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter

Financial Performance - Company reported revenue of $4.6 million for the third quarter of fiscal 2025, a decrease of 10.9% from $5.2 million in the same period last year [2][12] - Operating loss increased to $0.9 million from $0.4 million in the prior year [2][12] - Year-to-date revenues decreased slightly from $14.9 million to $14.5 million [12] Strategic Developments - Major overhaul of the marketing team and digital strategy has been completed to address the revenue decline [3] - The beverage brand, Oasis, has expanded distribution to 7 states, with e-commerce growth accelerating since July [3][7] - Company is actively engaging with industry associations and legislators to navigate regulatory changes impacting wholesale partners [3][4] Regulatory Environment - Recent positive developments at the national level include progress on the farm bill and cannabis scheduling discussions from the White House [4] - Increased regulatory scrutiny is expected to favor compliant brands and may drive industry consolidation, presenting opportunities for the company [4] Financial Position - As of June 30, 2025, the company had working capital of approximately $2.0 million and cash on hand of approximately $1.1 million, an improvement from a working capital deficit of $2.2 million the previous year [12] - The book value of equity increased significantly from $0.67 million to approximately $6.1 million following the conversion of Series A Preferred Stock [7] Sales Breakdown - Direct-to-consumer (DTC) net sales accounted for 78% of total net sales in the third quarter, totaling $3.6 million, compared to $3.9 million or 76% in the prior year [12] - Wholesale net sales were $1.0 million, representing 22% of total net sales, down from $1.2 million in the same quarter last year [12]